Loading…
Coordinating Dual Eligible Recommendations Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
Coordinating Dual Eligible Recommendations Act This bill requires the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission to jointly submit a biennial report on Medicare and Medicaid with respect to dually eligible beneficiaries, including information relating to finances, utilization, and coordination of services.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
R&D Tax Credit, S 880
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2023 · fourth_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. Legislative and administrative monitoring and outreach on use of artificial intelligence in healthcare H.R. 197, Rural Telehealth Expansion Act H.R. 198, Drug Pricing Transparency and Accountability Act H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023 H.R. 1066, CARING for Social Determinants Act of 2023 H.R. 1613, Drug Price Transparency in Medicaid Act of 2023 H.R. 1843, Telehealth Expansion Act of 2023 H.R. 2534, To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes. S. 127, Pharmacy Benefit Manager Transparency Act of 2023 S. 729, Audio-Only Telehealth for Emergencies Act S. 731, TELEHEALTH HSA Act of 2023 S. 880, Coordinating Dual Eligible Recommendations Act S. 1001, A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. S.113, Prescription pricing for the People Act S.1339, Pharmacy Benefit Manager Reform Act H.R. 3284, Providers and Payers Compete Act H.R. 3561, Patient Act S. 880, Coordinating Dual Eligible Recommendations Act H.R. 4697, Protecting PAHPA Act S.2624, Labor-HHS-Education Appropriations Act H.R. 5378, Lower Costs, More Transparency ActPrice Transparency H.R. 4368, Agriculture Appropriations Act S. 2131, Agriculture Appropriations Act H.R. 5860, Continuing Appropriations Act H.R.5894, Labor-HHS-Education Appropriations Act H.R. 6363, Further Continuing Appropriations Act H.R. 8487, Improving Seniors Timely Access to Care Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
R&D Tax Credit, S 880
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. H.R. 134, To amend title XVIII of the Social Security Act to remove geographic requirements and expand originating sites for telehealth services. H.R. 197, Rural Telehealth Expansion Act H.R. 198, Drug Pricing Transparency and Accountability Act H.R. 207, Advanced Safe Testing at Residence Telehealth Act of 2023 H.R. 497, Freedom for Health Care Workers Act H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023 H.R. 1066, CARING for Social Determinants Act of 2023 H.R. 1215, Healthcare Worker Retention Act H.R. 1488, Affordable Insulin Now Act H.R. 1587, Making Insulin Affordable for All Children Act H.R. 1613, Drug Price Transparency in Medicaid Act of 2023 H.R. 1843, Telehealth Expansion Act of 2023 H.R. 2534, To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes. S. 127, Pharmacy Benefit Manager Transparency Act of 2023 S. 146, Cap Insulin Prices Act S. 710, Striking and Locked Out Workers Healthcare Protection Act S. 729, Audio-Only Telehealth for Emergencies Act S. 731, TELEHEALTH HSA Act of 2023 S. 880, Coordinating Dual Eligible Recommendations Act S. 1001, A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. S.113, Prescription pricing for the People Act S.1339, Pharmacy Benefit Manager Reform Act H.R. 3284, Providers and Payers Compete Act H.R. 3561, Patient Act S. 880, Coordinating Dual Eligible Recommendations Act H.R. 4697, Protecting PAHPA Act S.2624, Labor-HHS-Education Appropriations Act H.R. 5378, Lower Costs, More Transparency ActPrice Transparency H.R. 4368, Agriculture Appropriations Act S. 2131, Agriculture Appropriations Act H.R. 5860, Continuing Appropriations Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
R&D Tax Credit, S 880
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. H.R. 134, To amend title XVIII of the Social Security Act to remove geographic requirements and expand originating sites for telehealth services. H.R. 197, Rural Telehealth Expansion Act H.R. 198, Drug Pricing Transparency and Accountability Act H.R. 207, Advanced Safe Testing at Residence Telehealth Act of 2023 H.R. 497, Freedom for Health Care Workers Act H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023 H.R. 1066, CARING for Social Determinants Act of 2023 H.R. 1215, Healthcare Worker Retention Act H.R. 1488, Affordable Insulin Now Act H.R. 1587, Making Insulin Affordable for All Children Act H.R. 1613, Drug Price Transparency in Medicaid Act of 2023 H.R. 1843, Telehealth Expansion Act of 2023 H.R. 2534, To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes. S. 127, Pharmacy Benefit Manager Transparency Act of 2023 S. 146, Cap Insulin Prices Act S. 710, Striking and Locked Out Workers Healthcare Protection Act S. 729, Audio-Only Telehealth for Emergencies Act S. 731, TELEHEALTH HSA Act of 2023 S. 880, Coordinating Dual Eligible Recommendations Act S. 1001, A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. S.113, Prescription pricing for the People Act S.1339, Pharmacy Benefit Manager Reform Act H.R. 3284, Providers and Payers Compete Act H.R. 3561, Patient Act H.R. 3746, Fiscal Responsibility Act S. 880, Coordinating Dual Eligible Recommendations Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
R&D Tax Credit, S 880
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
R&D Tax Credit, S 880
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. H.R. 134, To amend title XVIII of the Social Security Act to remove geographic requirements and expand originating sites for telehealth services. H.R. 197, Rural Telehealth Expansion Act H.R. 198, Drug Pricing Transparency and Accountability Act H.R. 207, Advanced Safe Testing at Residence Telehealth Act of 2023 H.R. 497, Freedom for Health Care Workers Act H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023 H.R. 1066, CARING for Social Determinants Act of 2023 H.R. 1215, Healthcare Worker Retention Act H.R. 1488, Affordable Insulin Now Act H.R. 1587, Making Insulin Affordable for All Children Act H.R. 1613, Drug Price Transparency in Medicaid Act of 2023 H.R. 1843, Telehealth Expansion Act of 2023 H.R. 2534, To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes. S. 127, Pharmacy Benefit Manager Transparency Act of 2023 S. 146, Cap Insulin Prices Act S. 710, Striking and Locked Out Workers Healthcare Protection Act S. 729, Audio-Only Telehealth for Emergencies Act S. 731, TELEHEALTH HSA Act of 2023 S. 880, Coordinating Dual Eligible Recommendations Act S. 1001, A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE